Coimbra hosts summit on the evolution of advanced therapies in Portugal
General
Click aqui para a versão em português.
.jpg)
On 17 November, Coimbra will host the ATMP Summit, organised by the European Advanced Translational Medical Research Infrastructure (EATRIS) and co-organised by the University of Coimbra (UC). The meeting will take place at the Instituto Pedro Nunes (IPN) between 9:00 a.m. and 7:30 p.m., focusing on the development and impact of advanced therapies based on genes, tissues or cells.
Under the theme The importance of advanced therapies in the current context, the meeting will welcome 16 national and international speakers from academia and regulatory bodies in the fields of health and industry, such as the vice-president of INFARMED, Carlos Lima Alves, and researchers Sheila Mikhail and Jude Samulski, who are involved in gene therapy.
The sessions will focus on the latest scientific advances in Portugal in translational research, innovation, manufacturing, regulation and future guidelines for advanced therapy medicinal products. Alongside the debate on the main challenges and opportunities in the area, an exhibition of companies will highlight the Portuguese industry active in this field, with the presence of several companies.
The ATMP Summit will bring together researchers, biotechnology companies, regulators, doctors, patient representatives and the public. The event aims to promote knowledge exchange, collaboration and real-world impact, reinforcing Portugal's role in the European ecosystem of innovative therapies. Participation is free, but subject to prior registration by 10 November at https://ls.uc.pt/index.php/575513
The president of the Centre for Neuroscience and Cell Biology at UC (CNC-UC) and GeneT: Centre of Excellence in Gene Therapy, Luís Pereira de Almeida; the director of Innovation at IPN, Jorge Pimenta; Ricardo Silva, researcher at the Institute of Experimental and Technological Biology (iBET); Sílvia Almeida, Scientific Director of AccelBio; and Patrícia Dias, coordinator of the Clinical Trials Centre of the Coimbra Local Health Unit, are other speakers at the event, representing organisations that are part of the European consortium EATRIS.
The ATMP Summit is held in the context of EATRIS Spotlight, a year-long programme dedicated to showcasing the best in translational medicine in Portugal, following the country's accession to the European entity EATRIS in July 2019. The event in Coimbra is co-organised by CNC-UC and the national entities of the consortium.
The programme is available here.
On 17 November, Coimbra will host the ATMP Summit, organised by the European Advanced Translational Medical Research Infrastructure (EATRIS) and co-organised by the University of Coimbra (UC). The meeting will take place at the Instituto Pedro Nunes (IPN) between 9:00 a.m. and 7:30 p.m., focusing on the development and impact of advanced therapies based on genes, tissues or cells.
Under the theme The importance of advanced therapies in the current context, the meeting will welcome 16 national and international speakers from academia and regulatory bodies in the fields of health and industry, such as the vice-president of INFARMED, Carlos Lima Alves, and researchers Sheila Mikhail and Jude Samulski, who are involved in gene therapy.
The sessions will focus on the latest scientific advances in Portugal in translational research, innovation, manufacturing, regulation and future guidelines for advanced therapy medicinal products. Alongside the debate on the main challenges and opportunities in the area, an exhibition of companies will highlight the Portuguese industry active in this field, with the presence of several companies.
The ATMP Summit will bring together researchers, biotechnology companies, regulators, doctors, patient representatives and the public. The event aims to promote knowledge exchange, collaboration and real-world impact, reinforcing Portugal's role in the European ecosystem of innovative therapies. Participation is free, but subject to prior registration by 10 November at https://ls.uc.pt/index.php/575513
The president of the Centre for Neuroscience and Cell Biology at UC (CNC-UC) and GeneT: Centre of Excellence in Gene Therapy, Luís Pereira de Almeida; the director of Innovation at IPN, Jorge Pimenta; Ricardo Silva, researcher at the Institute of Experimental and Technological Biology (iBET); Sílvia Almeida, Scientific Director of AccelBio; and Patrícia Dias, coordinator of the Clinical Trials Centre of the Coimbra Local Health Unit, are other speakers at the event, representing organisations that are part of the European consortium EATRIS.
The ATMP Summit is held in the context of EATRIS Spotlight, a year-long programme dedicated to showcasing the best in translational medicine in Portugal, following the country's accession to the European entity EATRIS in July 2019. The event in Coimbra is co-organised by CNC-UC and the national entities of the consortium.
The programme is available here.
